The US House has extended to Medicare recipients temporary waivers for telehealth coverage that was put in place at the onset of the COVID-19 pandemic. The legislation now moves to the Senate where it’s also expected to pass.
As the COVID-19 pandemic postponed non-emergency hospital visits, many Americans turned to telehealth for the first time as the frequency of virtual visits skyrocketed.
Join thousands of industry professionals who rely on Medtech Insight for daily insights
Already a subscriber?
Now that a federal judge has ruled the US FDA exceeded its authority by unilaterally assuming regulatory oversight of lab-developed tests, what’s the agency’s next move? And does it really have one?
Medical devices, diagnostics, and equipment face tariffs announced by President Donald Trump, despite industry pleas for exemption. The tariffs, ranging from 10%-49%, impact most countries trading with the US, potentially hindering innovation and increasing costs in the medtech sector.
Energy and Commerce Health Subcommittee Democrats focus on criticizing HHS Secretary Kennedy’s RIF announcement, including 3,500 FDA jobs among cuts across HHS agencies. Representatives were left wondering if user fee programs would continue, even if reauthorized.
AdvaMed’s top priorities for the 119th Congress include modernizing US Medicare services and expanding patients’ access to the latest medical technologies.
Well over 200 European standards need harmonizing under the MDR. But only around 12% have been attended to so far.
The medtech industry hopes to use a 90-day pause on tariffs to negotiate a “zero for zero” exemption. However, recent public comments from President Donald Trump suggest the health care sector may still be at risk.
The architect of Germany’s hospital reform, Karl Lauterbach, will not be retained as health minister according to how the new CDU/CSU-SPD coalition government plans to spread the ministerial portfolios.
